E. Schlick

1.1k total citations
51 papers, 968 citations indexed

About

E. Schlick is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, E. Schlick has authored 51 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 12 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in E. Schlick's work include Immune Response and Inflammation (11 papers), Immune Cell Function and Interaction (7 papers) and Neutropenia and Cancer Infections (5 papers). E. Schlick is often cited by papers focused on Immune Response and Inflammation (11 papers), Immune Cell Function and Interaction (7 papers) and Neutropenia and Cancer Infections (5 papers). E. Schlick collaborates with scholars based in United States, Germany and Poland. E. Schlick's co-authors include G. Keilhauer, P. Alken, G. Mickisch, K. D. Friedberg, R. Tschada, J. Kempeni, Michael A. Chirigos, Bertram Wiedenmann, R. Ruffmann and H C Stevenson and has published in prestigious journals such as Blood, Cancer Research and British Journal of Cancer.

In The Last Decade

E. Schlick

49 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Schlick United States 16 327 312 204 133 81 51 968
Philip Marder United States 17 265 0.8× 418 1.3× 237 1.2× 68 0.5× 60 0.7× 45 929
F. Spreafico Italy 16 229 0.7× 357 1.1× 294 1.4× 90 0.7× 36 0.4× 55 906
A.M.E. Nouri United Kingdom 16 398 1.2× 292 0.9× 200 1.0× 56 0.4× 70 0.9× 62 1.1k
Richard B. Nimberg United States 14 251 0.8× 290 0.9× 166 0.8× 44 0.3× 90 1.1× 26 805
H. U. Gubler Japan 8 292 0.9× 467 1.5× 154 0.8× 98 0.7× 141 1.7× 10 1.4k
Lorea Mendoza Spain 17 323 1.0× 536 1.7× 283 1.4× 86 0.6× 88 1.1× 21 1.1k
K H Stenzel United States 18 311 1.0× 336 1.1× 101 0.5× 36 0.3× 125 1.5× 39 943
Satoshi Funakoshi Japan 22 535 1.6× 739 2.4× 206 1.0× 92 0.7× 90 1.1× 72 1.6k
Shinsei Gasa Japan 21 189 0.6× 754 2.4× 86 0.4× 221 1.7× 69 0.9× 81 1.2k
Martin Hibbs United Kingdom 15 227 0.7× 419 1.3× 64 0.3× 247 1.9× 41 0.5× 25 1.0k

Countries citing papers authored by E. Schlick

Since Specialization
Citations

This map shows the geographic impact of E. Schlick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schlick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schlick more than expected).

Fields of papers citing papers by E. Schlick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Schlick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schlick. The network helps show where E. Schlick may publish in the future.

Co-authorship network of co-authors of E. Schlick

This figure shows the co-authorship network connecting the top 25 collaborators of E. Schlick. A scholar is included among the top collaborators of E. Schlick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Schlick. E. Schlick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keilhauer, G., Cynthia A. Romerdahl, H. Küpper, & E. Schlick. (1994). Modulation of Multidrug-Resistant Tumors by Dexverapamil. Oncology Research and Treatment. 17(6). 572–576. 2 indexed citations
2.
Poveda, Andrés, Carlos Fernández-Martos, Miguel Ángel Suárez Muñóz, et al.. (1992). Phase I study of mitonafide in solid tumors. Investigational New Drugs. 10(3). 177–181. 32 indexed citations
3.
Nokta, Mostafa, et al.. (1991). In Vivo Administration of Tumor Necrosis Factor-  is Associated with Antiviral Activity in Human Peripheral Mononuclear Cells. Experimental Biology and Medicine. 197(2). 144–149. 10 indexed citations
4.
Räth, U., M Kaufmann, Bertram Wiedenmann, et al.. (1991). Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites. European Journal of Cancer and Clinical Oncology. 27(2). 121–125. 53 indexed citations
5.
Mickisch, G., et al.. (1991). Circumvention of Multidrug Resistance Mediated by P-170 Glycoprotein Using Calcium Antagonists in Primary Human Renal Cell Carcinoma. Urologia Internationalis. 47(3). 118–125. 9 indexed citations
6.
Möller, Achim, et al.. (1990). Monoclonal antibodies to human tumor necrosis factor α: In vitro and in vivo application. Cytokine. 2(3). 162–169. 53 indexed citations
7.
Kaufmann, Max, H. Schmid, U. Raeth, et al.. (1990). Aszites-Therapie mit Tumornekrosefaktor beim Ovarialkarzinom. Geburtshilfe und Frauenheilkunde. 50(9). 678–682. 12 indexed citations
8.
Mickisch, G., et al.. (1990). Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT). Urological Research. 18(2). 131–136. 109 indexed citations
9.
Männel, D, Andreas M. Kist, U. Räth, et al.. (1989). Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor. British Journal of Cancer. 60(4). 585–588. 10 indexed citations
10.
Merry, Stephen, et al.. (1989). Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil. British Journal of Cancer. 59(6). 895–897. 16 indexed citations
11.
Schlick, E., et al.. (1987). Immune response by biological response modifiers.. PubMed. 1. 385–97. 1 indexed citations
12.
Ruffmann, R., et al.. (1986). Proteinmangel, Körperabwehr und natürliche Anti-Tumor-Immunität. Transfusion Medicine and Hemotherapy. 13(2). 106–112. 1 indexed citations
13.
Schlick, E., et al.. (1985). Effects of poly(I,C)-LC on growth and differentiation of normal and malignant myelopoietic progenitor cells.. PubMed. 4(6). 628–33. 2 indexed citations
14.
Talmadge, James E., Hamblin Phillips, Margaret S. Collins, et al.. (1985). Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.. PubMed. 45(3). 1058–65. 42 indexed citations
15.
Chirigos, M. A., et al.. (1985). Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC].. PubMed. 4(6). 621–7. 3 indexed citations
16.
Schlick, E., et al.. (1984). Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC.. Progress in clinical and biological research. 161. 467–79. 8 indexed citations
17.
Schlick, E., et al.. (1984). Biological characterization of MVE-2 and poly ICLC.. Progress in clinical and biological research. 161. 511–24. 1 indexed citations
18.
Krönke, Martin, J M Depper, E. Schlick, et al.. (1984). Monoclonal anti tac antibody a suitable carrier for immunotoxin therapy in adult t cell leukemia. 3(4). 253. 1 indexed citations
19.
Hartung, K, E. Schlick, H C Stevenson, & M. A. Chirigos. (1983). Prostaglandin E Synthesis and Release by Murine Macrophages and Human Monocytes After in Vitro Treatment with Biological Response Modifiers. PubMed. 5(3). 129–146. 11 indexed citations
20.
Bartocci, A., et al.. (1982). Enhancing activity of various immunoaugmenting agents on the delayed-type hypersensitivity response in mice.. Cancer Research. 42(9). 3514–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Marder Breakdown of academic impact, for papers by F. Spreafico Breakdown of academic impact, for papers by A.M.E. Nouri Breakdown of academic impact, for papers by Richard B. Nimberg Breakdown of academic impact, for papers by H. U. Gubler Breakdown of academic impact, for papers by Lorea Mendoza Breakdown of academic impact, for papers by K H Stenzel Breakdown of academic impact, for papers by Satoshi Funakoshi Breakdown of academic impact, for papers by Shinsei Gasa Breakdown of academic impact, for papers by Martin Hibbs
Rankless by CCL
2026